Akums Drugs & Pharmaceuticals
AKUMS · Pharma > Pharmaceuticals & Drugs Listing date: Aug. 6, 2024

Stock Price vs Company Growth
1d
5.0%
1w
4.7%
1m
32.5%
3m
35.2%
all
23.4%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 610 5.0%
527
970
Company Overview

Sales
4,203 Cr
Growth: 11.8%
Profit after Tax
-35 Cr
Growth: -87.7%
Mid Cap
9,600 Cr
P/S: 2.3x
Industry P/S: 3.1x
Fundamentals

Sales (Cr) ₹ 4,203
Growth 11.8%
EBITDA 6.6%
P/S 2.3x
Dividend 0.0%
P/E -258.5x
Book Value ₹ 1.95
PEG Ratio -21.9x
ROE -120.2%
P/B N/A
Shareholding Pattern

Increase    Decrease    No change
Company Profile Detailed

As a CDMO, the company produces an extensive range of dosage forms including tablets, capsules, liquid orals, vials, ampoules, blow-filled seals, topical preparations, eye drops, dry powder injections, and gummies, among others. It also engages in the marketing of trade generic and products under its own brand through distributors and alternative channels across India. Key Awards and accreditations2018: Received India Pharma Leader Award by Government of India.